EU Notified Bodies 'Under Pressure And Scared'
Executive Summary
Being under the spotlight nearly all decade has changed the workload and stress levels for notified bodies. Inevitably, some are dropping, but how challenging is it for those who are surviving and need to adapt?
You may also be interested in...
EU Medtech Ecosystem Will Suffer Unless Notified Body Workload Concerns Are Addressed – The German View
An EU notified body redesignation rate of 10 per year is too slow. It won't help small companies using the new Medical Device and IVD Regulation systems, and is leaving NBs feeling let down and with a mountain to climb. A German industry group weighs in on the need to speed up redesignations.
With EU Notified Body Numbers Tumbling, How Do Manufacturers Ensure Seamless Transition To MDR?
Device manufacturers in the EU are beginning to realize the extra volume of MDR/IVDR-related work that their pivotal market access partners, the notified bodies, will have to take on. With the regulations' three- and five-year transition period clocks ticking down already, manufacturers must make sure that business continuity is guaranteed – but it won't be easy.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.